CFDE Workbench
DataKnowledgeCloudtrainingcoordination
CFDE Workbench

COL P01029-1 GLY 000330 (Collection)

Taxon:

Mus musculus

Taxonomy (Entity type)
Ptm:

p01029-1 1387asn 1387asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)
Protein:

CO4B MOUSE

Protein (Entity type)
Project:

Portal

Project (Entity type)
Dcc Asset:

glygen 2026 06 06 C2M2.zip

Processed File (Entity type)
Dcc:

GlyGen

DCC (Entity type)
Collection:

mouse proteoform glycosylation sites glyconnect.csv

File (Entity type)
Anatomy:

blood serum

Anatomy (Entity type)
Description:Information for protein P01029-1 in the context of file GLY_000330
Creation Time:2026-03-02 20:00:31.000000
Results found

Linked to

 

Label

Description

 

File

mouse proteoform glycosylation sites glyconnect.csv

File (Entity type)

A 2.06 MB file from GlyGen as part of the Portal project

Anatomy

blood serum

Anatomy (Entity type)

The portion of blood plasma that excludes clotting factors.

Compound

G15569GG

Compound (Entity type)

type="Composition" mass="2254.77283515" permass="2829.41448802" monosaccharides="11" is_motif="False...

Compound

G15488CF

Compound (Entity type)

type="Composition" mass="2400.83074402" permass="3003.50369703" monosaccharides="12" is_motif="False...

Compound

G40608DF

Compound (Entity type)

type="Saccharide" mass="2254.77283515" permass="2829.41448802" monosaccharides="11" is_motif="False"...

Compound

G39397SW

Compound (Entity type)

type="Saccharide" mass="2400.83074402" permass="3003.50369703" monosaccharides="12" is_motif="False"...

Protein

CO4B MOUSE

Protein (Entity type)

Complement C4-B

Post Translational Modification

p01029-1 1387asn 1387asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

  • File

    mouse proteoform glycosylation sites glyconnect.csv

    File (Entity type)

    A 2.06 MB file from GlyGen as part of the Portal project

  • Anatomy

    blood serum

    Anatomy (Entity type)

    The portion of blood plasma that excludes clotting factors.

  • Compound

    G15569GG

    Compound (Entity type)

    type="Composition" mass="2254.77283515" permass="2829.41448802" monosaccharides="11" is_motif="False...

  • Compound

    G15488CF

    Compound (Entity type)

    type="Composition" mass="2400.83074402" permass="3003.50369703" monosaccharides="12" is_motif="False...

  • Compound

    G40608DF

    Compound (Entity type)

    type="Saccharide" mass="2254.77283515" permass="2829.41448802" monosaccharides="11" is_motif="False"...

  • Compound

    G39397SW

    Compound (Entity type)

    type="Saccharide" mass="2400.83074402" permass="3003.50369703" monosaccharides="12" is_motif="False"...

  • Protein

    CO4B MOUSE

    Protein (Entity type)

    Complement C4-B

  • Post Translational Modification

    p01029-1 1387asn 1387asn defined go:0006486 go:0006487

    Post Translational Modification (Entity type)

    A Post Translational Modification

    • DISPLAY PER PAGE
    CFDE Workbench
    Report a bug
    Consortium
    About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
    Community
    Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
    Resources
    Data & MetadataToolsChatbotUse CasesPublications
    @CFDE Workbench 2026
    The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
    Consortium
    About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
    Community
    Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
    Resources
    Data & MetadataToolsChatbotUse CasesPublications
    CFDE Workbench
    Report a bug
    The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
    @CFDE Workbench 2026
    This repository is under review for potential modification in compliance with Administration directives.